✦ LIBER ✦

2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor

✍ Scribed by Hanus, L.

Book ID: 111950615
Publisher: National Academy of Sciences
Year: 2001
Tongue: English
Weight: 113 KB
Volume: 98
Category: Article
ISSN: 0027-8424
DOI: 10.1073/pnas.061029898

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hemopressin is an inverse agonist of CB1

Hemopressin is an inverse agonist of CB1 cannabinoid receptors

✍ Heimann, A. S.; Gomes, I.; Dale, C. S.; Pagano, R. L.; Gupta, A.; de Souza, L. L 📂 Article 📅 2007 🏛 National Academy of Sciences 🌐 English ⚖ 362 KB

Selective cannabinoid receptor 2 (CB2R)

Selective cannabinoid receptor 2 (CB2R) agonist AM1710 acts independently of cannabinoid receptor 1 (CB1R) responses in neuropathic CB1R -/- mice

✍ J. Wilkerson; L. Alberti; J. Wallace; A. Kerwin; E. Dengler; B. Bowman; P. Plate 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 36 KB

Oleamide is a selective endogenous agoni

Oleamide is a selective endogenous agonist of rat and human CB1 cannabinoid receptors

✍ James D Leggett; S Aspley; S R G Beckett; A M D'Antona; D A Kendall; D A Kendall 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 296 KB

AM630 is an inverse agonist at the human

AM630 is an inverse agonist at the human cannabinoid CB1 receptor

✍ Robert S. Landsman; Alexandros Makriyannis; Hongfeng Deng; Paul Consroe; William 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 405 KB

Binding affinity and agonist activity of

Binding affinity and agonist activity of putative endogenous cannabinoids at the human neocortical CB1 receptor

✍ Marc Steffens; Josef Zentner; Jürgen Honegger; Thomas J. Feuerstein 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 328 KB

An expedient atom-efficient synthesis of

An expedient atom-efficient synthesis of the cannabinoid CB1 receptor inverse agonist ibipinabant

✍ Jos H.M. Lange; Hans J. Sanders; Jeroen van Rheenen 📂 Article 📅 2011 🏛 Elsevier Science 🌐 French ⚖ 314 KB

A novel synthetic route to the highly selective and orally active cannabinoid CB 1 receptor inverse agonist ibipinabant is described which combines the use of inexpensive, commercially available reagents and mild reaction conditions with a high degree of atom-efficiency. The method is expected to en